We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCRB icon
1301
Seres Therapeutics
MCRB
$48.9M
$14K ﹤0.01%
105
+1
+1% +$196
RIGL icon
1302
Rigel Pharmaceuticals
RIGL
$750M
$14K ﹤0.01%
390
+2
+0.5% +$79
RYTM icon
1303
Rhythm Pharmaceuticals
RYTM
$7.96B
$14K ﹤0.01%
1,145
USNA icon
1304
Usana Health Sciences
USNA
$286M
$14K ﹤0.01%
158
XENE icon
1305
Xenon Pharmaceuticals
XENE
$6.12B
$14K ﹤0.01%
940
+5
+0.5% +$87
XPEV icon
1306
XPeng
XPEV
$11.6B
$14K ﹤0.01%
400
SPWR
1307
DELISTED
SunPower Corporation Common Stock
SPWR
$14K ﹤0.01%
644
AVDL
1308
DELISTED
Avadel Pharmaceuticals
AVDL
$13K ﹤0.01%
1,335
+5
+0.4% +$39
BEEM icon
1309
Beam Global
BEEM
$25.3M
$13K ﹤0.01%
478
DQ
1310
Daqo New Energy
DQ
$996M
$13K ﹤0.01%
242
FRPT icon
1311
Freshpet
FRPT
$3.22B
$13K ﹤0.01%
94
GEVO icon
1312
Gevo
GEVO
$382M
$13K ﹤0.01%
1,990
HLF icon
1313
Herbalife
HLF
$1.29B
$13K ﹤0.01%
308
HPQ icon
1314
HP
HPQ
$27.5B
$13K ﹤0.01%
510
+125
+32% +$3.59K
MGTX icon
1315
MeiraGTx Holdings
MGTX
$1.21B
$13K ﹤0.01%
1,010
PLRX icon
1316
Pliant Therapeutics
PLRX
$65M
$13K ﹤0.01%
820
+5
+0.6% +$106
RDUS
1317
DELISTED
Radius Recycling
RDUS
$13K ﹤0.01%
298
SPRO icon
1318
Spero Therapeutics
SPRO
$73M
$13K ﹤0.01%
730
+55
+8% +$883
VMEO
1319
DELISTED
Vimeo
VMEO
$13K ﹤0.01%
466
+47
+11% +$1.85K
FUV
1320
DELISTED
Arcimoto, Inc. Common Stock
FUV
$13K ﹤0.01%
59
SOLO
1321
DELISTED
Electrameccanica Vehicles Corp. Ltd.
SOLO
$13K ﹤0.01%
3,706
KDNY
1322
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$13K ﹤0.01%
1,025
+10
+1% +$132
RDUS
1323
DELISTED
Radius Health, Inc.
RDUS
$13K ﹤0.01%
1,080
+5
+0.5% +$72
TVTY
1324
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$13K ﹤0.01%
606
ACIU icon
1325
AC Immune
ACIU
$240M
$12K ﹤0.01%
1,820
+165
+10% +$1.18K

Similar funds

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.